Company Profiles

driven by the PitchBook Platform

Atreca

Description

Developer of novel therapeutics designed to focus on applications in cancer treatment. The company's novel therapeutics provide technology for the development of antibody-based therapeutics, vaccines, diagnostics and research reagents in therapy areas including cancer, infectious disease and autoimmune disease and also helps to measure and analyze the structure of clinically successful immune responses to identify antibodies, T cell receptors (TCRs), and targets that are key to successful treatment outcomes in patients, enabling patients to provide an immune response by the identification and generation of functional human antibodies and TCRs without prior knowledge of antigen.

2010

Founded

PRIVATE

Status

Series A

Latest Deal Type

$56M

Latest Deal Amount

$63.1M

Total Amount Raised

3

Investors

Description

Developer of novel therapeutics designed to focus on applications in cancer treatment. The company's novel therapeutics provide technology for the development of antibody-based therapeutics, vaccines, diagnostics and research reagents in therapy areas including cancer, infectious disease and autoimmune disease and also helps to measure and analyze the structure of clinically successful immune responses to identify antibodies, T cell receptors (TCRs), and targets that are key to successful treatment outcomes in patients, enabling patients to provide an immune response by the identification and generation of functional human antibodies and TCRs without prior knowledge of antigen.

Website:

www.atreca.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery
Drug Delivery

Primary Office

500 Saginaw Drive First Floor Redwood City, CA 94063United States +1 (650) 595-2595
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Atreca's full profile, request a free trial.

Atreca Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Atreca Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Atreca Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Bill & Melinda Gates FoundationNot-For-Profit Venture CapitalMinority000 0000000 0000
GlaxoSmithKlineCorporationMinority000 0000000 0000
Mission Bay CapitalVenture CapitalMinority000 0000000 0000
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital
GlaxoSmithKline Corporation
Mission Bay Capital Venture Capital

Atreca Executive Team (12)

NameTitleBoard
Seat
Contact
Info
Tito Serafini Ph.DCo-Founder, Chief Executive Officer, Chief Scientific Officer, President & Board Member
Susan BerlandExecutive Vice President & Chief Financial Officer
Guy Cavet Ph.DCo-Founder & Chief Technology Officer
Norman Greenberg Ph.DSenior Vice President & Chief Scientific Officer
Nigel RaySenior Vice President and Chief Business Officer
Tito Serafini Ph.D Co-Founder, Chief Executive Officer, Chief Scientific Officer, President & Board Member
Susan Berland Executive Vice President & Chief Financial Officer
Guy Cavet Ph.D Co-Founder & Chief Technology Officer
Norman Greenberg Ph.D Senior Vice President & Chief Scientific Officer
Nigel Ray Senior Vice President and Chief Business Officer

Atreca Board Members (8)

NameRepresentingRoleSinceContact
Info
Andrew FarnumBill & Melinda Gates FoundationSenior Program Investment Officer000 0000
Brian AtwoodSelfChairman000 0000
David Lacey MDSelfBoard Member000 0000
Douglas Crawford Ph.DMission Bay CapitalFounder & Managing Director000 0000
Franklin BergerAtrecaBoard Member000 0000
Andrew Farnum Senior Program Investment Officer Bill & Melinda Gates Foundation
Brian Atwood Chairman Self
David Lacey MD Board Member Self
Douglas Crawford Ph.D Founder & Managing Director Mission Bay Capital
Franklin Berger Board Member Atreca
Request full access to PitchBook